Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

BI Spevigo September 2023

DO, MPH

Can patients treated with spesolimab receive live vaccines? 

Generalized Pustular Psoriasis (GPP)

You. That's a little bit of a tricky question. The correct answer is no. And we know from the package insert, it specifically states to avoid the use of live vaccines in patients treated with spazolamov. There have not been specific studies for this agent in clinical trials where subjects have recently received live viral or live bacterial vaccines. Now, I do want to point out, and I'll make a caveat here, that this is Brad Glick speaking. It's me as an individual. It's not dermbits, it's not bi the company that makes the company that produces this product. But I want to say that in some cases, this condition can be really health threatening, life threatening with significant potential morbidity and mortality. And so I think in emerging circumstances, if one were to have known that a recent live vaccine was administered, then I don't personally think that Spizolamov should be withheld. And I just wanted to point that out. But the correct answer is no, we really don't know. And live vaccines should not be traditionally administered in the setting of using spizolumov for treating generalized pushular psoriasis.

Can patients treated with spesolimab receive live vaccines?

Related CME